SBIR/STTR Reauthorization Act Of 2011
U.S. Department of Health & Human Services Logo
 
Grants and Funding
Funding Opportunities
Funding Opportunities (RFAs, PAs) & Notices
Unsolicited Applications (Parent Announcements)
Research Training & Career Development
Small Business (SBIR/STTR)
Funding Opportunities
Electronic Submission
Application Submission/Review
Policy
Resources
Transitioning to Phase III
Presentations/Conferences
Archive
LISTSERVS
Contract Opportunities
 
NIH-Wide Initiatives
New and Early Stage Investigators
Stem Cell Information
NIH Common Fund
OppNet (Behavioral & Social Sciences)
 
Award Data
NIH Reports (RePORT)
Search NIH Awards (RePORTER)
SBIR/STTR Reauthorization Act Of 2011: NIH Implementation Of Key Changes

Increased Support for Commercialization
Key Changes (Provided by SBA) NIH IMPLEMENTATION

Commercialization Readiness Programs. DoD Commercialization Readiness Pilot is made permanent and includes the STTR program; Commercialization Readiness Pilot programs for civilian agencies are authorized allowing agencies to use up to 10% of SBIR/STTR funds to support commercialization and Phase III efforts.

Stay tuned. NIH is considering a Commercialization Readiness Program.

Phase III preference. Agencies directed to support SBIR/STTR awardees in their efforts to commercialize SBIR/STTR work through, among other things, Phase III sole-source contracts.

NIH is not typically the purchaser of products developed with SBIR and STTR funds. This is most commonly done by the Department of Defense. In those rare cases where NIH might purchase, NIH will support Phase III sole-source contracts.


SBIR/STTR Reauthorization Act Of 2011 Home

This page last updated on August 30, 2012
Technical Issues: E-mail OER Webmaster

Social Media Links